behavior therapy
Recently Published Documents


TOTAL DOCUMENTS

5128
(FIVE YEARS 779)

H-INDEX

121
(FIVE YEARS 10)

2022 ◽  
Vol 14 (1) ◽  
pp. 319-333
Author(s):  
Zheng-Gen Lin ◽  
Ren-Dong Li ◽  
Fu-Lu Ai ◽  
Song Li ◽  
Xin-An Zhang

Psychotherapy ◽  
2022 ◽  
Author(s):  
Maria C. Alba ◽  
Katharine T. Bailey ◽  
Kathryn A. Coniglio ◽  
Jesse Finkelstein ◽  
Shireen L. Rizvi

Author(s):  
Jennifer Poon ◽  
Janine N. Galione ◽  
Lauren R. Grocott ◽  
Karyn J. Horowitz ◽  
Anastacia Y. Kudinova ◽  
...  

2022 ◽  
pp. 1-13
Author(s):  
Mengfei Ye ◽  
Mengna Shou ◽  
Jian Zhang ◽  
Baiqi Hu ◽  
Chunyan Liu ◽  
...  

Abstract Background T long-term effects of cognitive therapy and behavior therapy (CTBT) for menopausal symptoms are unknown, and whether the effects are different between natural menopause and treatment-induced menopause are currently unclear. Therefore, we sought to conduct an accurate estimate of the efficacy of CTBT for menopausal symptoms. Methods We conducted searches of Cochrane Library, EMBASE, PsycINFO, PubMed, and Web of Science databases for studies from 1 January 1977 to 1 November 2021. Randomized controlled trials (RCTs) comparing intervention groups to control groups for menopausal symptoms were included. Hedge's g was used as the standardized between-group effect size with a random-effects model. Results We included 14 RCTs comprising 1618 patients with a mean sample size of 116. CTBT significantly outperformed control groups in terms of reducing hot flushes [g = 0.39, 95% confidence interval (CI) 0.23–0.55, I2 = 45], night sweats, depression (g = 0.50, 95% CI 0.34–0.66, I2 = 51), anxiety (g = 0.38, 95% CI 0.23–0.54, I2 = 49), fatigue, and quality of life. Egger's test indicated no publication bias. Conclusions CTBT is an effective psychological treatment for menopausal symptoms, with predominantly small to moderate effects. The efficacy is sustained long-term, although it declines somewhat over time. The efficacy was stronger for natural menopause symptoms, such as vasomotor symptoms, than for treatment-induced menopause symptoms. These findings provide support for treatment guidelines recommending CTBT as a treatment option for menopausal symptoms.


2022 ◽  
pp. 1-9
Author(s):  
Maria Picó-Pérez ◽  
Miquel A. Fullana ◽  
Anton Albajes-Eizagirre ◽  
Daniel Vega ◽  
Josep Marco-Pallarés ◽  
...  

Abstract Background Cognitive-behavior therapy (CBT) is a well-established first-line intervention for anxiety-related disorders, including specific phobia, social anxiety disorder, panic disorder/agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, and posttraumatic stress disorder. Several neural predictors of CBT outcome for anxiety-related disorders have been proposed, but previous results are inconsistent. Methods We conducted a systematic review and meta-analysis of task-based functional magnetic resonance imaging (fMRI) studies investigating whole-brain predictors of CBT outcome in anxiety-related disorders (17 studies, n = 442). Results Across different tasks, we observed that brain response in a network of regions involved in salience and interoception processing, encompassing fronto-insular (the right inferior frontal gyrus-anterior insular cortex) and fronto-limbic (the dorsomedial prefrontal cortex-dorsal anterior cingulate cortex) cortices was strongly associated with a positive CBT outcome. Conclusions Our results suggest that there are robust neural predictors of CBT outcome in anxiety-related disorders that may eventually lead (probably in combination with other data) to develop personalized approaches for the treatment of these mental disorders.


Sign in / Sign up

Export Citation Format

Share Document